219 related articles for article (PubMed ID: 22872761)
1. Regulation of the androgen receptor by post-translational modifications.
Coffey K; Robson CN
J Endocrinol; 2012 Nov; 215(2):221-37. PubMed ID: 22872761
[TBL] [Abstract][Full Text] [Related]
2. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
Lumahan LEV; Arif M; Whitener AE; Yi P
Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
[TBL] [Abstract][Full Text] [Related]
3. Posttranslational modification of the androgen receptor in prostate cancer.
van der Steen T; Tindall DJ; Huang H
Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
[TBL] [Abstract][Full Text] [Related]
4. Post-translational modifications of nuclear receptors and human disease.
Anbalagan M; Huderson B; Murphy L; Rowan BG
Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
[TBL] [Abstract][Full Text] [Related]
5. Post-translational modification of the androgen receptor.
Gioeli D; Paschal BM
Mol Cell Endocrinol; 2012 Apr; 352(1-2):70-8. PubMed ID: 21820033
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor splicing variant 7: Beyond being a constitutively active variant.
Shao C; Yu B; Liu Y
Life Sci; 2019 Oct; 234():116768. PubMed ID: 31445027
[TBL] [Abstract][Full Text] [Related]
7. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
Cherian MT; Wilson EM; Shapiro DJ
J Biol Chem; 2012 Jul; 287(28):23368-80. PubMed ID: 22589544
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitinating enzyme USP26 is a regulator of androgen receptor signaling.
Dirac AM; Bernards R
Mol Cancer Res; 2010 Jun; 8(6):844-54. PubMed ID: 20501646
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
Baniahmad A
J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
[TBL] [Abstract][Full Text] [Related]
10. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
[TBL] [Abstract][Full Text] [Related]
11. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
[TBL] [Abstract][Full Text] [Related]
12. Endocrine mechanisms of disease: Expression and degradation of androgen receptor: mechanism and clinical implication.
Lee DK; Chang C
J Clin Endocrinol Metab; 2003 Sep; 88(9):4043-54. PubMed ID: 12970260
[TBL] [Abstract][Full Text] [Related]
13. A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells.
Auvin S; Öztürk H; Abaci YT; Mautino G; Meyer-Losic F; Jollivet F; Bashir T; de Thé H; Sahin U
Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31431473
[TBL] [Abstract][Full Text] [Related]
14. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen.
Wolf DA; Herzinger T; Hermeking H; Blaschke D; Hörz W
Mol Endocrinol; 1993 Jul; 7(7):924-36. PubMed ID: 8413317
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor phosphorylation: biological context and functional consequences.
Koryakina Y; Ta HQ; Gioeli D
Endocr Relat Cancer; 2014 Aug; 21(4):T131-45. PubMed ID: 24424504
[TBL] [Abstract][Full Text] [Related]
18. Androgen action and metabolism in prostate cancer.
Green SM; Mostaghel EA; Nelson PS
Mol Cell Endocrinol; 2012 Sep; 360(1-2):3-13. PubMed ID: 22453214
[TBL] [Abstract][Full Text] [Related]
19. Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer.
Lv S; Song Q; Chen G; Cheng E; Chen W; Cole R; Wu Z; Pascal LE; Wang K; Wipf P; Nelson JB; Wei Q; Huang W; Wang Z
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33332287
[TBL] [Abstract][Full Text] [Related]
20. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.
Jin F; Fondell JD
Nucleic Acids Res; 2009 Aug; 37(14):4826-38. PubMed ID: 19520769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]